Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Oct;59(4):834-8.

Apparent gene conversions involving the SMN gene in the region of the spinal muscular atrophy locus on chromosome 5

Affiliations

Apparent gene conversions involving the SMN gene in the region of the spinal muscular atrophy locus on chromosome 5

G van der Steege et al. Am J Hum Genet. 1996 Oct.

Abstract

The survival motor neuron (SMN) gene has been described as a determining gene for spinal muscular atrophy (SMA). SMN has a closely flanking, nearly identical copy (cBCD541). Gene and copy gene can be discriminated by sequence differences in exons 7 and 8. The large majority of SMA patients show homozygous deletions of at least exons 7 and 8 of the SMN gene. A minority of patients show absence of SMN exon 7 but retention of exon 8. This is explained by results of our present analysis of 13 such patients providing evidence for apparent gene-conversion events between SMN and the centromeric copy gene. Instead of applying a separate analysis for absence or presence of SMN exons 7 and 8, we used a contiguous PCR from intron 6 to exon 8. In every case we found a chimeric gene with a fusion of exon 7 of the copy gene and exon 8 of SMN and absence of a normal SMN gene. Similar events, including the fusion counterpart, were observed in a group of controls, although in the presence of a normal SMN gene. Chimeric genes as the result of fusions of parts of SMN and cBCD541 apparently are far from rare and may partly explain the frequently observed SMN deletions in SMA patients.

PubMed Disclaimer

References

    1. J Clin Invest. 1990 Jan;85(1):219-22 - PubMed
    1. Hum Mol Genet. 1996 Feb;5(2):257-63 - PubMed
    1. Nature. 1990 Apr 19;344(6268):767-8 - PubMed
    1. Nature. 1990 Jun 28;345(6278):823-5 - PubMed
    1. Lancet. 1990 Aug 4;336(8710):271-3 - PubMed

Publication types

Substances

Grants and funding